These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25908420)

  • 1. [The clinical significance of the levels of serum KL-6 mucin and interleukin-13 in pulmonary alveolar proteinosis].
    Zhou J; Xiao Y; Ding J; Zhou K; Zhou Z; Cai H
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Feb; 38(2):110-4. PubMed ID: 25908420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.
    Bonella F; Ohshimo S; Miaotian C; Griese M; Guzman J; Costabel U
    Orphanet J Rare Dis; 2013 Apr; 8():53. PubMed ID: 23557396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.
    Nara M; Sano K; Ogawa H; Tamada T; Nagaoka M; Okada K; Watanabe M; Moriya T; Miki H; Nakata K; Ichinose M; Hattori T
    Tohoku J Exp Med; 2006 Apr; 208(4):349-54. PubMed ID: 16565598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.
    Boyce DSK; Lee JW; Shah P; Freeman JH; Aboudara MC; Hostler DC
    BMC Pulm Med; 2019 Mar; 19(1):61. PubMed ID: 30866900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
    Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chang GD; Chern MS; Chen YC; Chang SC
    Thorax; 2006 Jun; 61(6):528-34. PubMed ID: 16517574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-Macrophage Colony-Stimulating Factor Inhalation Therapy for Severe Pulmonary Alveolar Proteinosis.
    Zhen G; Li D; Jiang J; Weng Y
    Am J Ther; 2020 Mar; 28(2):e171-e178. PubMed ID: 31513019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.
    Bonella F; Long X; Ohshimo S; Horimasu Y; Griese M; Guzman J; Kohno N; Costabel U
    Orphanet J Rare Dis; 2016 Apr; 11():48. PubMed ID: 27108412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic investigation of the detection of granulocyte-macrophage colony stimulating factor antibody in serum for pulmonary alveolar proteinosis].
    Li YQ; Chen YS; Li HR; Shang Y; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):351-6. PubMed ID: 24047809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
    Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R
    BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis.
    Yu Hy; Sun Xf; Wang Yx; Xu Zj; Huang H
    BMC Pulm Med; 2014 May; 14():87. PubMed ID: 24886114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bilateral total lung lavage in a patient with pulmonary alveolar proteinosis].
    Erbay M; Bülbül Y; Öztuna F; Kılıç M; Özçelik N; Ersöz Ş
    Tuberk Toraks; 2017 Sep; 65(3):249-254. PubMed ID: 29135404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.
    Arai T; Hamano E; Inoue Y; Ryushi T; Nukiwa T; Sakatani M; Nakata K
    Respir Med; 2004 Dec; 98(12):1227-30. PubMed ID: 15588045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
    Hirose M; Arai T; Sugimoto C; Takimoto T; Sugawara R; Minomo S; Shintani S; Takeuchi N; Katayama K; Inoue Y; Kagawa T; Kasai T; Akira M; Inoue Y
    Orphanet J Rare Dis; 2021 Mar; 16(1):115. PubMed ID: 33653382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.
    Tokura S; Akira M; Okuma T; Tazawa R; Arai T; Sugimoto C; Matsumuro A; Hirose M; Takada T; Nakata K; Ishii H; Kasahara Y; Hojo M; Ohkouchi S; Tsuchihashi Y; Yokoba M; Eda R; Nakayama H; Nei T; Morimoto K; Nasuhara Y; Ebina M; Ichiwata T; Tatsumi K; Yamaguchi E; Inoue Y
    Ann Am Thorac Soc; 2017 Sep; 14(9):1403-1411. PubMed ID: 28489417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis for treatment of pulmonary alveolar proteinosis.
    Luisetti M; Rodi G; Perotti C; Campo I; Mariani F; Pozzi E; Trapnell BC
    Eur Respir J; 2009 May; 33(5):1220-2. PubMed ID: 19407056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
    Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
    Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.